BG
BEAT

BlackRock Group’s BioTelemetry, Inc. BEAT Stock Holding History

BlackRock Group’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1M Buy
44,748
+24,205
+118% +$473K ﹤0.01% 2135
2016
Q3 		$381K Buy
+20,543
New +$387K ﹤0.01% 2401
2015
Q4 		– Sell
-21,001
Closed -$257K – 3124
2015
Q3 		$257K Hold
21,001
– – ﹤0.01% 2448
2015
Q2 		$198K Buy
21,001
+12,192
+138% +$113K ﹤0.01% 2577
2015
Q1 		$78K Buy
+8,809
New +$89K ﹤0.01% 2703

Other funds holding BEAT

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

BlackRock Group's BEAT Position: Q4 2016 in Review

BlackRock Group increased its BioTelemetry, Inc. (BEAT) stake by 118% in Q4 2016, buying an estimated $473K and bringing the position to 44,748 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #2135.

BlackRock Group first reported a position in BEAT in Q1 2015 and has held it in 5 quarters since. 160 funds tracked by Wall St. Rank hold BEAT as of Q4 2016.

  • BlackRock Group held 44,748 shares of BioTelemetry, Inc. worth $1M as of Q4 2016.
  • BlackRock Group bought 24,205 BioTelemetry, Inc. shares in Q4 2016, an estimated $473K.
  • BioTelemetry, Inc. made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2135 holding.
  • BlackRock Group first reported a position in BioTelemetry, Inc. in Q1 2015 and has held it in 5 quarters since.
  • 160 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.